Join

Compare · ACHV vs LMDX

ACHV vs LMDX

Side-by-side comparison of Achieve Life Sciences Inc. (ACHV) and LumiraDx Limited (LMDX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ACHV and LMDX operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
  • LMDX is the larger of the two at $2.23B, about 3.1x ACHV ($717.2M).
  • ACHV has hit the wire 9 times in the past 4 weeks while LMDX has been quiet.
  • ACHV has more recent analyst coverage (11 ratings vs 4 for LMDX).
MetricACHVLMDX
Company
Achieve Life Sciences Inc.
LumiraDx Limited
Price
-
-
Market cap
$717.2M
$2.23B
1M return
-
-
1Y return
-
-
Sector
Health Care
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Exchange
NASDAQ
NASDAQ
IPO
News (4w)
9
0
Recent ratings
11
4
ACHV

Achieve Life Sciences Inc.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Latest ACHV

Latest LMDX